Home > > > > Report Detail

(Post-pandemic Era) - Global Genome Editing Market Segment Research Report 2022

Publisher Name :
Date: 02-Aug-2022
No. of pages: 86

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch) released the «(Post-pandemic Era)-Global Genome Editing Market Segment Research Report 2022», which aims to sort out the development status and trends of the Genome Editing industry at home and abroad, estimate the overall market scale of the Genome Editing industry and the market share of major countries, Genome Editing industry, and study and judge the downstream market demand of Genome Editing through systematic research, Analyze the competition pattern of Genome Editing, so as to help solve the pain points of various stakeholders in Genome Editing industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Genome Editing Market by XYZResearch Include

- USA

- Europe

- China

- Japan

- India

- Korea

- Southeast Asia

Competitive Analysis; Who are the Major Players in Genome Editing Market?

- Genscript

- Horizon Discovery Group

- Lonza

- Merck KGaA

- Sangamo Therapeutics

- Thermo Fisher Scientific

Major Type of Genome Editing Covered in XYZResearch report:

- CRISPR

- TALEN

- ZFN

Application Segments Covered in XYZResearch Market

- Cell Line Engineering

- Animal Genetic Engineering

- Plant Genetic Engineering

For any other requirements, please feel free to contact us and we will provide you customized report.

(Post-pandemic Era) - Global Genome Editing Market Segment Research Report 2022

Table of Contents

Global Genome Editing Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Genome Editing Market by Value
2.2.1 Global Genome Editing Revenue by Type
2.2.2 Global Genome Editing Market by Value
2.3 Global Genome Editing Market by Sales
2.3.1 Global Genome Editing Sales by Type
2.3.2 Global Genome Editing Market by Sales
3. The Major Driver of Genome Editing Industry
3.1 Historical & Forecast Global Genome Editing Sales and Revenue (2018-2028)
3.2 Largest Application for Genome Editing (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Genome Editing Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Genome Editing Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Genome Editing Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Genome Editing Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Genome Editing Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Genome Editing Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Genome Editing Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Genome Editing Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Genome Editing Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Genome Editing Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Genome Editing Average Price Trend
13.1 Market Price for Each Type of Genome Editing in US (2018-2022)
13.2 Market Price for Each Type of Genome Editing in Europe (2018-2022)
13.3 Market Price for Each Type of Genome Editing in China (2018-2022)
13.4 Market Price for Each Type of Genome Editing in Japan (2018-2022)
13.5 Market Price for Each Type of Genome Editing in India (2018-2022)
13.6 Market Price for Each Type of Genome Editing in Korea (2018-2022)
13.7 Market Price for Each Type of Genome Editing in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Genome Editing in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Genome Editing Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Genome Editing
15. Genome Editing Competitive Landscape
15.1 Genscript
15.1.1 Genscript Company Profiles
15.1.2 Genscript Product Introduction
15.1.3 Genscript Genome Editing Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Horizon Discovery Group
15.2.1 Horizon Discovery Group Company Profiles
15.2.2 Horizon Discovery Group Product Introduction
15.2.3 Horizon Discovery Group Genome Editing Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Lonza
15.3.1 Lonza Company Profiles
15.3.2 Lonza Product Introduction
15.3.3 Lonza Genome Editing Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Merck KGaA
15.4.1 Merck KGaA Company Profiles
15.4.2 Merck KGaA Product Introduction
15.4.3 Merck KGaA Genome Editing Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Sangamo Therapeutics
15.5.1 Sangamo Therapeutics Company Profiles
15.5.2 Sangamo Therapeutics Product Introduction
15.5.3 Sangamo Therapeutics Genome Editing Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Thermo Fisher Scientific
15.6.1 Thermo Fisher Scientific Company Profiles
15.6.2 Thermo Fisher Scientific Product Introduction
15.6.3 Thermo Fisher Scientific Genome Editing Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
16. Conclusion
17. Methodology and Data Source

List of Tables and Figures

Figure 1. Total Sales by Application of Genome Editing Industry (Volume)
Figure 2. Genome Editing Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Genome Editing Revenue in 2022
Figure 5. US Genome Editing Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Genome Editing Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Genome Editing Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Genome Editing Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Genome Editing Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Genome Editing Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Genome Editing Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Genome Editing Revenue, by Type (Million USD) (2018-2028)
Table 4. Genome Editing Sales, by Type (K Unit) (2018-2028)
Table 5. Genome Editing Sales (K Unit) by Application (2018-2028)
Table 6. Genome Editing Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Genome Editing Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Genome Editing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Genome Editing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Genome Editing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Genome Editing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Genome Editing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Genome Editing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Genome Editing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Genome Editing in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Genome Editing in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Genome Editing in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Genome Editing in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Genome Editing in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Genome Editing in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Genome Editing in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Genscript Profiles
Table 61. Genscript Genome Editing Product Introduction
Table 62. Genscript Genome Editing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Genscript Strategic initiatives
Table 64. Horizon Discovery Group Profiles
Table 65. Horizon Discovery Group Genome Editing Product Introduction
Table 66. Horizon Discovery Group Genome Editing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Horizon Discovery Group Strategic initiatives
Table 68. Lonza Profiles
Table 69. Lonza Genome Editing Product Introduction
Table 70. Lonza Genome Editing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Lonza Strategic initiatives
Table 72. Merck KGaA Profiles
Table 73. Merck KGaA Genome Editing Product Introduction
Table 74. Merck KGaA Genome Editing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Merck KGaA Strategic initiatives
Table 76. Sangamo Therapeutics Profiles
Table 77. Sangamo Therapeutics Genome Editing Product Introduction
Table 78. Sangamo Therapeutics Genome Editing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Sangamo Therapeutics Strategic initiatives
Table 80. Thermo Fisher Scientific Profiles
Table 81. Thermo Fisher Scientific Genome Editing Product Introduction
Table 82. Thermo Fisher Scientific Genome Editing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Thermo Fisher Scientific Strategic initiatives

  • Global Genome Editing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global Genome Editing market: According to our latest research, the global Genome Editing market looks promising in the next 5 years. As of 2022, the global Genome Editing market was estimated at USD 7377.87 million, and it's anticipated to reach USD 25474.29 million in 2028, with a CAGR of 22.94% during the forecast years. Genome editing is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organ......
  • Global Genome Editing Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 86
    Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. In 2018, the common methods for such editing use engineered nucleases, or "molecular scissors". These nucleases create site-specific double-strand breaks (DSBs) at desired locations in the genome. The induced double-strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), resulting in target......
  • Animal Genetics Market by Product (Live Animal (Poultry, Porcine, Bovine, Canine) Genetic Material (Semen (Bovine, Porcine, Equine), Embryo (Bovine, Equine)) Genetic Testing Service (Disease, Genetic Traits - Bovine, DNA Typing)) - Global Forecast to 2028
    Published: 10-Aug-2023        Price: US 4950 Onwards        Pages: 320
    Rising demand for livestock animals due to the growing population, increasing per capita income, and rapid urbanization will drive the market growth. The global animal genetics market is projected to reach USD 9.5 billion by 2028 from USD 6.6 billion in 2023, at a CAGR of 7.4% during the forecast period. The increasing consumption of animal products, adoption of advanced genetic testing methods, animal welfare activities, and demand for companion animals are fueling the growth of this......
  • Epigenetic Therapeutics: Global Markets
    Published: 01-Jun-2023        Price: US 5500 Onwards        Pages: 155
    Report Scope: This report is a comprehensive study of the global market for epigenetic therapeutics. It describes the epigenetic therapeutics market, which is segmented by product type and region. Based on product type, the market is segmented into PRAP inhibitors, Kinase inhibitors, IDH inhibitors, HDAC inhibitors, DNMT inhibitors and KMT inhibitors. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific, and the Rest of the World (RoW). ......
  • Genome Editing Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
    Published: 05-May-2023        Price: US 4150 Onwards        Pages: 146
    The study predicts the short term and long term trends that can shape up the future of the Genome Editing market including the COVID-19 pandemic implications for Genome Editings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies. ......
  • Global Genome Editing Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 16-Mar-2023        Price: US 3260 Onwards        Pages: 95
    Genome editing is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. Unlike early genetic engineering techniques that randomly inserts genetic material into a host genome, genome editing targets the insertions to site specific locations. The Genome Editing market revenue was 7377.87 Million USD in 2022, and will reach 25474.29 Million USD in 2028, with a CAGR of 22.94% during 2022-2028. This report elabo......
  • Global Genome Editing/Genome Engineering Market Status and Outlook 2023-2028
    Published: 01-Mar-2023        Price: US 3160 Onwards        Pages: 108
    Genome editing, or genome engineering, or gene editing, is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging ......
  • Global Genome Engineering Market Status and Outlook 2023-2028
    Published: 23-Feb-2023        Price: US 3160 Onwards        Pages: 107
    Genome editing, or genome engineering, or gene editing, is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. Unlike early genetic engineering techniques that randomly inserts genetic material into a host genome, genome editing targets the insertions to site specific locations. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in......
  • Global Genome Editing Market Research Report 2023
    Published: 07-Feb-2023        Price: US 2900 Onwards        Pages: 85
    Genome editing, or genome engineering is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. In 2018, the common methods for such editing use engineered nucleases, or "molecular scissors". These nucleases create site-specific double-strand breaks (DSBs) at desired locations in the genome. The induced double-strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), resulting in target......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs